It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

The first drug shown to slow Alzheimer's disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.